Zhi Yu
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 11
- Systemic Lupus Erythematosus Research 7
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes 5
- Hematology top 5%
- Acute Myeloid Leukemia Research 6
- Genetics top 10%
- Genetic Associations and Epidemiology 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Rehabilitation top 5%
-
- Lipoproteins and Cardiovascular Health 5
-
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- Xuan WangBin XuChong-Xi YuanWenjie MaJosef CoreshMireille McleanAshkan AfshinDariush Mozaffarian
- Cited by
- RheumatologyNephrologyHematology
- Journals
- Circulation (2 papers)Blood (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Zhi Yu
62 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Rheumatology 276
- Nephrology 123
- Hematology 162
- Genetics 138
- Rehabilitation 81
Countries citing papers authored by Zhi Yu
This map shows the geographic impact of Zhi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Yu more than expected).
Fields of papers citing papers by Zhi Yu
This network shows the impact of papers produced by Zhi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Yu. The network helps show where Zhi Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhi Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesisbreakdown → | 2024 | 36 |
| 5 | 2024 | 15 | |
| 6 | 2023 | 14 | |
| 7 | Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Diseasebreakdown → | 2023 | 83 |
| 8 | 2023 | 4 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 94 | |
| 11 | 2022 | 2 | |
| 12 | 2021 | 39 | |
| 13 | 2020 | 81 | |
| 14 | 2020 | 23 | |
| 15 | 2018 | 18 | |
| 16 | 2018 | 41 | |
| 17 | 2018 | 19 | |
| 18 | 2017 | 8 | |
| 19 | 2016 | 81 | |
| 20 | 2016 | 4 |
About Zhi Yu
Zhi Yu is a scholar working on Nephrology, Rheumatology and Hematology, having authored 67 papers that have together received 1.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (11 papers), Genetic Associations and Epidemiology (8 papers), Systemic Lupus Erythematosus Research (7 papers), Acute Myeloid Leukemia Research (6 papers), Lipoproteins and Cardiovascular Health (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Chronic Kidney Disease and Diabetes (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Rheumatology (276 citations), Nephrology (123 citations) and Hematology (162 citations). Zhi Yu has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Xuan Wang, Bin Xu, Chong-Xi Yuan, Wenjie Ma, Josef Coresh, Mireille Mclean, Ashkan Afshin, Dariush Mozaffarian, Mandana Arabi and Morgan E. Grams. Their work appears in journals such as Circulation, Blood and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.